Women Face Criminal Charges Over Pregnancy For Medical Cannabis Use, Record Number Of Prosecutions In Year After Dobbs

Zinger Key Points
  • Over 200 pregnant women faced criminal charges for conduct related to pregnancy, abortion, pregnancy loss or birth in the year after Dobbs.
  • That’s according to a report from Pregnancy Justice, a reproductive rights organization.
  • Following methamphetamines, cannabis was the second most common substance appearing in 86 of the total number of cases.

Over two hundred pregnant women faced criminal charges for conduct related to pregnancy, abortion, pregnancy loss or birth during the first year following the Dobbs v. Jackson Women's Health Organization decision. Some women faced prosecution for using medical marijuana, despite being registered patients under state law, as highlighted by Marijuana Moment's Ben Adlin.

That's according to a report from Pregnancy Justice, a reproductive rights organization, titled "Pregnancy as a Crime: A Preliminary Report on the First Year After Dobbs."

Following the landmark decision of the U.S. Supreme Court to overrule Roe v. Wade and Planned Parenthood v. Casey, eliminating the constitutional right to abortion 2022, dated June 24, 2022, a sharp increase in pregnancy-related prosecutions is evident.

The report found that "in the one year from June 24, 2022, to June 23, 2023, there was the highest number of pregnancy-related prosecutions documented in a single year." 

Nearly 97% of 210 criminal cases filed cited substance use during pregnancy.

In 133 of those cases, drug use was the only allegation made. Following methamphetamines, cannabis was the second most common drug appearing in 86 of the total number of cases.

"It is significant that, in eighty-six cases, the police or prosecution alleged that the defendant took some form of THC during her pregnancy, and in thirty-one of those eighty-six cases, the only allegation supporting prosecution was THC use," the report said. "Even more startling, in five of those cases, the court file included statements that the defendant had a medical marijuana card, indicating that she was being charged with taking legally prescribed medication."

Read Also: Canadian Study Raises Alarm About Cannabis Use During Pregnancy As ER And Hospital Visits Increase

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

Research On Cannabis And Pregnancy

Meanwhile, the growing body of research shows opposing results when it comes to cannabis use in pregnancy.

A recent study from the Hebrew University in collaboration with the Hadassah Medical Center examined the potential long-term risks of prenatal cannabis use on children's neurological development. The research which included more than 500,000 participants, found that THC, a molecule found in cannabis, can cross the placenta and potentially influence the developing fetal brain. The connection between marijuana use during pregnancy and autism, schizophrenia or depression was not confirmed by researchers.

Separately, a study published in the journal Nature Mental Health (via Health Day News) on July 4, 2024, reveals that children exposed to cannabis in utero exhibit brain patterns indicative of reduced inflammation, which could hinder critical developmental processes. The study, led by David Baranger, a postdoctoral fellow at Washington University in St. Louis, did find that prenatal cannabis exposure might influence the developing brain in ways associated with mental health.

Read Next:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsHealth CareTop Storiescannabis pregnanvyCBDPregnancy JusticeTHC
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.